Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Naing A

Collect these papers and discover other ones on Labmeeting. Learn more.

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.

+ cite this

+ View Abstract

Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, Moulder S, Wheler JJ, Naing A, Tannir NM, Ng CS, Sherman SI, El Naggar AK, Khan R, Trent J, Wright JJ,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 15(22):7061-8, 2009 Nov 15 - Who cited this? | PubMed ID: 19903778 | Fulltext

Phase I clinical trials in 56 patients with thyroid cancer: the m. D. Anderson cancer center experience.

+ cite this

+ View Abstract

Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, and Kurzrock R

The Journal of clinical endocrinology and metabolism 94(11):4423-32, 2009 Nov - Who cited this? | PubMed ID: 19820016 | Fulltext

Survival of patients in a Phase 1 clinic: the M. D. Anderson Cancer Center Experience.

+ cite this

+ View Abstract

Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, Feng L, and Kurzrock R

Cancer 115(5):1091-9, 2009 Mar 1 - Who cited this? | PubMed ID: 19165805 | Fulltext

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.

+ cite this

+ View Abstract

Nakamura R, Rodriguez R, Palmer J, Stein A, Naing A, Tsai N, Chang K, Slovak ML, Bhatia R, Spielberger R, Kogut N, Pullarkat V, Kirschbaum M, Forman SJ, and O'Donnell MR

Bone marrow transplantation 40(9):843-50, 2007 Nov - Who cited this? | PubMed ID: 17724447 | Fulltext

Developmental therapeutics for myelodysplastic syndromes.

+ cite this

+ View Abstract

Naing A, Sokol L, and List AF

Journal of the National Comprehensive Cancer Network : JNCCN 4(1):78-82, 2006 Jan - Who cited this? | PubMed ID: 16403406 | Fulltext

Methotrexate-induced status epilepticus.

+ cite this

Naing A, Luong D, and Extermann M

American journal of hematology 80(1):35-7, 2005 Sep - Who cited this? | PubMed ID: 16138356 | Fulltext

Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root.

+ cite this

Naing A, Messina JL, Vrionis FR, and Daud AI

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(15):3194-5, 2004 Aug 1 - Who cited this? | PubMed ID: 15284274 | Fulltext

Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathy.

+ cite this

+ View Abstract

Hanutsaha P, Guyer DR, Yannuzzi LA, Naing A, Slakter JS, Sorenson JS, Spaide RF, Freund KB, Feinsod M, and Orlock DA

Ophthalmology 105(9):1632-6, 1998 Sep - Who cited this? | PubMed ID: 9754169 | Fulltext

Search Google Scholar for Naing A

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!